
Once Weekly Insulin Efsitora Alfa Shows Similar Efficacy to Daily Insulin
Investigational once weekly insulin efsitora alfa met the primary end point of noninferior A1c reduction compared to daily basal insulin for patients with type 2 diabetes. The results from QWINT-1 (NCT05662332), QWINT-3 (NCT05275400), and QWINT-4 ( …